Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Single Arm, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Next Previous
X
Search
Trial Profile

A Multicenter, Single Arm, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 29 Jul 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Satralizumab (Primary) ; Azathioprine; Mycophenolate mofetil; Prednisolone
  • Indications Neuromyelitis optica
  • Focus Adverse reactions; Registrational
  • Acronyms SAkuraMoon
  • Sponsors Roche

    • Most Recent Events

    • 14 Jun 2024 Status changed from active, no longer recruiting to completed.
    • 18 Apr 2024 Results of Updated Analysis of Long-term Efficacy of Satralizumab , presented at the 76th Annual Meeting of the American Academy of Neurology 2024
    • 13 Oct 2023 Results assessing the long-term efficacy of satralizumab in patients with aquaporin-4-IgG-seropositive (AQP4 IgG+) neuromyelitis optica spectrum disorder, presented at the 9th Triennial joint meeting of Americas Committee for Treatment and Research in Multiple Sclerosis and the European Committee for Treatment and Research in Multiple Sclerosis.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top